Mary Beth Lewis Insider Profile
4 Followers
Mary Beth Lewis, Director at Eterna Therapeutics, holds 40.00K shares in Eterna Therapeutics (Ticker: ERNA). Most recently, Mary Beth Lewis Bought 30,000 shares of Eterna Therapeutics on Aug 25, 2010 for an estimated value of $5.40K.
Mary Beth Lewis's Trading History
| ERNAEterna Therapeutics | Aug 25, 2010 | Director | Informative Buy | 5.40K | $67.60K | |
You May Also Like
Mary Beth Lewis insider profile FAQ
What is the percentage of profitable transactions made by Mary Beth Lewis?
The percentage of profitable transactions made by Mary Beth Lewis is 50%.
What is the average return per transaction made by Mary Beth Lewis?
The average return per transaction made by Mary Beth Lewis is 23.10%.
What stocks does Mary Beth Lewis hold?
Mary Beth Lewis holds: ERNA stocks.
What was Mary Beth Lewis’s latest transaction?
Mary Beth Lewis’s latest transaction was an Informative Buy of $5.40K.
What was Mary Beth Lewis's most profitable transaction?
Mary Beth Lewis’s most profitable transaction was an Informative Buy of ERNA stock on May 27, 2009. The return on the trade was 48.60%.
What is Mary Beth Lewis's role in Eterna Therapeutics?
Mary Beth Lewis's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
